Nel ASA's Autumn Crossroads: Can a Record Order Intake Outrun the Cash Burn?
Published on 08/11/2026 at 18:12 | Redaktion boerse-global.de
For a company that just posted its strongest quarterly order intake in years, Nel ASA has been oddly quiet. The Norwegian hydrogen specialist's shares have drifted since mid-July, when the resignation of chief executive HĂĄkon Volldal and second-quarter results landed within days of each other. That lull, however, masks a period of genuine consequence: the board is hunting for a successor while investors weigh whether the recent demand surge is a genuine inflection point or a temporary reprieve.
The stock currently changes hands at around €0.1986, roughly 45.7 percent below its 52-week high of €0.3655, a peak reached as recently as May. The gap to the 50-day moving average stands at minus 9.07 percent, suggesting the market is pricing in operational weakness rather than future order momentum. At the same time, the shares sit about 14.7 percent above the 52-week trough of €0.1731, leaving room for cautious optimism if execution improves.
The Core Tension: Orders Versus Cash
The central question facing Nel is straightforward: can it convert its order backlog of roughly 1.2 billion Norwegian kroner into recognized revenue before its cash buffer runs dangerously thin? At the end of the second quarter, the company held 1.328 billion kroner in cash — a notable drawdown from the 1.928 billion kroner it held a year earlier.
The quarter itself was a study in contrasts. Order intake surged 224 percent year-on-year to 230 million kroner, the strongest figure in recent memory, while the order book expanded to 1.213 billion kroner. Yet revenue from customer contracts fell 12 percent to 153 million kroner, and the net loss widened to 189 million kroner from 131 million kroner in the prior-year quarter. The EBITDA figure stood at minus 155 million kroner, a deterioration from minus 86 million kroner a year earlier, though a one-off charge of 70 million kroner related to the Iwatani settlement weighed on the result. Excluding that item, adjusted EBITDA remained broadly stable year-on-year.
Both electrolyzer segments contributed to the revenue decline — alkaline sales dropped 14 percent and PEM sales fell 10 percent year-on-year — underscoring the gap between order momentum and actual invoicing.
The Bull Case: Technology and External Validation
Optimists point to the PA-Series, the pressurized alkaline platform that launched commercially in May, as the catalyst that could change Nel's trajectory. The company claims the technology reduces floor space requirements by 80 percent and capital costs by 40 to 60 percent — figures that, if confirmed in series production, would materially strengthen its competitive position. A €135 million grant from the European Union for the PA-Series manufacturing line adds third-party validation to those claims.
The order pipeline shows early signs of traction. Two orders for containerized PEM solutions, each worth roughly $7 million, arrived during the quarter, and Nel expanded its partner network with companies such as SMA Altenso and container integrators in the US and Europe. The ongoing collaboration with Reliance in India, aimed at establishing a gigafactory, remains a focal point — a binding next step there would signal the kind of international scalability Nel has yet to demonstrate.
Management's capacity roadmap calls for 500 megawatts of production capability by the end of 2026, scaling to 1 gigawatt in 2027. The existing cash reserve should allow the company to navigate the leadership transition without immediate financing pressure, provided the order momentum holds.
The Bear Case: A Widening Execution Gap
Skeptics see a different picture. The 12 percent revenue decline suggests that converting backlog into billings remains a persistent challenge, and the widening EBITDA loss points to a company still far from profitability. If order conversion continues to lag while capacity-building expenses accelerate, the cash position could erode faster than planned.
The leadership vacuum adds another layer of uncertainty. Volldal announced his departure in June to pursue another professional opportunity, and his six-month notice period means he is expected to exit around mid-December 2026. Until a successor is named, strategic decisions — on capacity adjustments, new investments, or further partnerships — risk being deferred. The Iwatani settlement, which has already dented quarterly results once, remains an open item whose full financial implications are not yet clear.
While Nel navigates its leadership transition, your own operational risks deserve the same scrutiny. Many employers overlook gaps in their workplace risk documentation until an incident forces the issue. A free toolkit with 41 ready-to-use templates and checklists helps you document hazards properly and stay compliant. Download the free Risk Assessment Toolkit
The share price's persistent discount to its 50-day average suggests the market currently weighs these operational concerns more heavily than the order book strength.
What to Watch Next
The near-term direction hinges on whether order intake can sustain the second-quarter pace and whether the cash buffer holds. If both conditions are met, a gradual stabilization scenario remains plausible even without a confirmed CEO. Should demand falter or cash burn accelerate, Nel would face the unenviable task of managing a leadership transition alongside deteriorating fundamentals.
Two milestones will provide clarity. The first is the appointment of a new chief executive, due before Volldal's scheduled departure in mid-December 2026. The second, more immediate test comes with the third-quarter report on October 21, 2026 — the first opportunity to see whether the record order intake has begun translating into actual revenue, and whether the succession question has been resolved. Until then, the order book remains the metric that will determine which of Nel's two narratives prevails.
